Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Ann Rheum Dis. 2010 Dec 13;70(3):508–511. doi: 10.1136/ard.2009.120899

Table 2.

Odds ratios and attributable proportions due to interaction for different doses of smoking and SE alleles, regarding the risk to develop ACPA positive RA.

No SE Heterozygotic
SE (SSE)
Homozygotic SE
(DSE)
Smoking dose No.
ca/co*
OR (95 % CI) No. ca/co* OR (95 % CI) No. ca/co* OR (95 % CI)

No Smoke 38/154 1.0 (REF) § 107/150 3.2 (2.0 - 4.9) 62/43 6.3 (3.7 - 10.9)

 0 - 9 pack years 25/104 1.0 (0.6 - 1.8) 80/96 3.4 (2.1 - 5.6) 54/19 12.0 (6.2 - 23.0)
AP** … … …
… … … … ……….. 0.09 (−0.32-0.49) … … … … 0.47 (0.12 - 0.83)

 10 - 19 pack-years 18/68 1.2 (0.6 - 2.2) 83/56 7.3 (4.3 - 12.4) 43/10 24.6 (10.9 - 55.8)
AP** … … …
… … … … ……….. 0.53 (0.30 - 0.76) … … … … 0.73 (0.50 - 0.95)

 20- pack years 30/87 1.9 (1.1 - 3.5) 112/71 8.7 (5.3 - 14.4) 83/13 37.6 (18.3 - 77.4)
AP** … … …
… … … … ……….. 0.51 (0.31 - 0.72) … … … … 0.80 (0.67 - 0.94)

p-value for trend p = 0.11 p < 0.0001 p < 0.0001
*

Number of exposed (exp) cases (ca) and controls (co),

**

Attributable proportion due to interaction (AP),

Odds ratio (OR) and corresponding 95 percent confidence interval (95% CI) adjusted for sex, age and residential area,

§

Reference category.